Scott Hirsch

Biography

Mr. Scott Hirsch has been Senior Vice President of Business Strategy at Valeant Pharmaceuticals International, Inc. since August 2016 and has been its Chief Business Strategy Officer since June 19, 2017. Mr. Hirsch is a seasoned investment professional with a deep knowledge of the specialty pharmaceutical industry. He joined Valeant from Citadel Investment Group, where he oversaw equity investments and risk management decisions within the Health Care sector at Surveyor Capital. Prior to joining Valeant, Mr. Hirsch was a Portfolio Manager at Citadel, Surveyor Capital overseeing equity investments and risk management decisions within the Health Care sector. Prior to Citadel, he was the Lead Equity Research Analyst covering Specialty Pharmaceuticals and Global Generics for Credit Suisse. Mr. Hirsch also has five years of experience in venture capital operating roles at JP Morgan Partners and Morgan Stanley Ventures portfolio companies, which included the development of health care marketing technologies subsequently acquired by WebMD. He holds an MBA in Healthcare Management and Finance from Wharton and BFA from Rhode Island School of Design.

Research Interest

Healthcare Management and Finance